
Company is part of limited distribution for a Lundbeck neurologic treatment
Muted reaction to revelations of the Physician's Sunshine Act
Agreement with KEW Group brings genetic screening and a pathway program
Thomson Reuters Bioworld report tracks biosimilar development
Payer trends dominate near-term outlook
New study suspects Indian manufacturers 'differentiate drug quality according to the destination of consumption'
DHL garners headlines with a 'parcelcopter' delivering daily drugs to remote North Sea island
New facility at Innomar Strategies adds capacity and resources
Pharma companies will need to do more than rely on pharmacies' adjudication of claims
Regulatory compliance continues to exceed cost as a primary driver
Skycell AG's combination of advanced insulation and thermodynamic control provides landed-cost savings
Emphasis placed on high-level security in data transfers
Brings ongoing GS1 standards development into alignment with the DSCSA
Pharma supply chain managers gather to address logistics issues
New service from J. Knipper debuts at PDMA Sharing Conference
Vendor-managed system inventories and protects specialty pharmaceuticals in healthcare settings
Jon Giacomin replaces Kaufmann as CEO of Cardinal Pharmaceutical segment
BuzzeoPDMA's optimally located sample distribution saves up to 30% on logistics costs
Generically available drug is also the subject of FDA hearings over safety and efficacy
CustomerTimes touts its mobile apps
Lozenges, powders, chewable or effervescent versions should be considered, says Hermes Pharma
'Compliant' drug information for physicians is one targeted goal
Tobacco-free drugstores are just part of the story
Among the various 'metal' health plans, coverage increases as premiums go up, says HealthPocket.com
Pharmaceutical Commerce sat down with Mr. Mortazavi recently; here's what he had to say.
Absence of agreed-on FDA guidance keeps biosimilars off the US market even as their use grows abroad
Battlefield over drug pricing
Blackstone Group-owned CDMO nets over $800 million
After patent expires, 'The industry has turned a corner'